Malignancy Spectrum is a new open access journal publishing original work from cancer researchers around the globe, along with reviews on emerging areas of cancer research and treatment, and opinion pieces. Malignancy Spectrum publishes quality and impactful work spanning areas ranging from epidemiology to immunotherapy for the treatment of metastatic disease, and provides a platform dedicated to work focusing on novel emerging areas of cancer research, including but not limited to aging and cancer, geriatric oncology, and palliative care. Article publication charges are currently waived, so there are no fees for publishing open access. The Editor-in-Chief is professor Qimin Zhan at Peking University Cancer Hospital, and the co-editrors-in-Chief are professors Weimin Li at West China Hospital, Sichuan University, Wei Fu at Peking University Third Hospital, and Conor C. Lynch at the Moffitt Cancer Center, USA.